![]() ![]() How to store COVID-19 mRNA Vaccine BNT162b2.How COVID-19 mRNA Vaccine BNT162b2 is given.What you need to know before you receive COVID-19 mRNA Vaccine BNT162b2.What COVID-19 mRNA Vaccine BNT162b2 is and what it is used for.This includes any possible side effects not listed in this leaflet. If you get any side effects, talk to your doctor, pharmacist or nurse.If you have any further questions, ask your doctor, pharmacist or nurse. ![]() Read all of this leaflet carefully before you receive this vaccine because it contains important information for you. Package leaflet: Information for the recipient See the end of section 4 for how to report side effects. You can help by reporting any side effects you may get. Reporting of side effectsĪs with any new medicine in the UK this product will be closely monitored to allow quick identification of new safety information. It does not have a marketing authorisation, but this temporary authorisation grants permission for the medicine to be used for active immunisation to prevent COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 12 years of age and over. This medicinal product has been given authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines & Healthcare products Regulatory Agency. Regulation 174 Information for UK recipients COVID-19 mRNA Vaccine BNT162b2 concentrate for solution for injection tozinameran Please see here for latest product information. Stock authorised under Regulation 174 is no longer in use.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |